Plus, news about Vericel:
AN2 Therapeutics adopts poison pill: The small molecule drugmaker put forth the stockholder rights plan for a …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Rancho Cucamonga, 06/30/2023 / 13:05, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. RANCHO CUCAMONGA, CA / ACCESSWIRE / June 30, 2023 / Amphastar Pharmaceuticals,
SAN ANTONIO — A drug approved for hypoactive sexual desire disorder (HSDD) in premenopausal women also improved sexual dysfunction in some men, according to a
The FDA expanded the approval of benralizumab (Fasenra) to include treatment of younger kids with uncontrolled severe asthma with an eosinophilic phenotype, AstraZeneca announced on